First-Of-Its-Kind Ketamine Prescribing Service Now Available to Psychotherapists
A new first-of-its-kind ketamine prescribing service comes to independent psychotherapists using the dissociative with their patients.
A new first-of-its-kind ketamine prescribing service comes to independent psychotherapists using the dissociative with their patients.
Ketamine may offer new hope for sufferers of treatment resistant depression via an extended-release oral administered option.
Psychedelic biotech company PharmaTher says its ketamine patch could help relieve depression better than other treatments.
Canada gets its first chair for psychedelic research thanks to private citizen funding to the University of Calgary.
A new device may help Cybin better understand the psychedelic impact of the drug ketamine on the human brain.
Research into ketamine as a potential treatment for Parkinson’s patients suffering from drug side effects is getting FDA approval.
There’s new hope for depressed and suicidal patients with ketamine therapy, says University of Alabama doctor Richard C. Shelton.
New treatment interventions approved by NIMH for use with high-suicide risks include two novel ketamine therapies.
A nasal spray of ketamine proved to be highly effective at treating a type of migraine called refractory migraines, according to a new study.
Ketamine may be a useful treatment for diabetes and obesity, according to a new patent filed by psychedelic company PharmTher.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.